Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.26 USD | -0.30% | -2.07% | -34.06% |
Apr. 30 | Neogen® Launches New Molecular Method for Detection of Two Salmonella Serotypes | CI |
Apr. 18 | Neogen Corporation Forms Genomics Relationship with Performance Food Group | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- Low profitability weakens the company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-34.06% | 2.87B | C | ||
-5.56% | 181B | C+ | ||
-0.11% | 108B | C | ||
-6.17% | 66.12B | A | ||
+2.64% | 50.65B | B- | ||
+6.58% | 43.66B | B- | ||
+4.91% | 41.3B | B+ | ||
+21.98% | 31.6B | B | ||
+14.45% | 25.03B | A- | ||
-5.81% | 24.16B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- NEOG Stock
- Ratings Neogen Corporation